Childhood atopic dermatitis: current developments, treatment approaches, and future expectations

Area of Science:

• Dermatology
• Immunology
• Genetics

Background:

• Atopic dermatitis (AD) is the most prevalent chronic inflammatory skin disorder in children.
• Its pathophysiology involves impaired skin barrier, altered lipid composition, immune dysregulation (e.g., Th2/Th1 ratio, cytokines, T regulatory cells), genetic, and epigenetic factors.
• Current understanding of AD pathogenesis is incomplete, with ongoing research revealing further complexities.

Purpose of the Study:

• To review the current understanding of pathogenic mechanisms in atopic dermatitis.
• To evaluate existing and novel therapeutic agents for AD.
• To highlight the often-overlooked personal, familial, and economic burdens of AD.

Main Methods:

• Literature review of pathogenic mechanisms in atopic dermatitis.
• Analysis of current and emerging treatment options for AD.
• Examination of the disease's impact on patients, families, and economies.

Main Results:

• AD pathogenesis is multifactorial, involving skin barrier dysfunction and immune system imbalances.
• Existing therapies offer only temporary relief and do not cure AD.
• Recent advances in understanding AD mechanisms have led to promising new treatments and ongoing clinical trials.

Conclusions:

• Further elucidation of AD pathophysiology is crucial for developing effective treatments.
• Novel therapeutic agents show promise in addressing the complexities of AD.
• Addressing the comprehensive burden of AD, including its societal impact, is essential.